FR2854400A1 - COMPOSES SILANYL-n ALCANAL, LEUR PROCEDE DE PREPARATION ET LEURS UTILISATIONS - Google Patents

COMPOSES SILANYL-n ALCANAL, LEUR PROCEDE DE PREPARATION ET LEURS UTILISATIONS

Info

Publication number
FR2854400A1
FR2854400A1 FR0305391A FR0305391A FR2854400A1 FR 2854400 A1 FR2854400 A1 FR 2854400A1 FR 0305391 A FR0305391 A FR 0305391A FR 0305391 A FR0305391 A FR 0305391A FR 2854400 A1 FR2854400 A1 FR 2854400A1
Authority
FR
France
Prior art keywords
compounds
silanyl
alcanal
preparation
solid supports
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR0305391A
Other languages
English (en)
Other versions
FR2854400B1 (fr
Inventor
Francoise Vinet
Gerard Lanneau
Michel Granier
Franck Martin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Universite Montpellier 2 Sciences et Techniques
Commissariat a lEnergie Atomique et aux Energies Alternatives CEA
Original Assignee
Centre National de la Recherche Scientifique CNRS
Commissariat a lEnergie Atomique CEA
Universite Montpellier 2 Sciences et Techniques
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, Commissariat a lEnergie Atomique CEA, Universite Montpellier 2 Sciences et Techniques filed Critical Centre National de la Recherche Scientifique CNRS
Priority to FR0305391A priority Critical patent/FR2854400B1/fr
Priority to JP2006505821A priority patent/JP4781261B2/ja
Priority to EP04742596A priority patent/EP1626977A2/fr
Priority to PCT/FR2004/001030 priority patent/WO2004099219A2/fr
Priority to US10/554,742 priority patent/US7442823B2/en
Publication of FR2854400A1 publication Critical patent/FR2854400A1/fr
Application granted granted Critical
Publication of FR2854400B1 publication Critical patent/FR2854400B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0896—Compounds with a Si-H linkage
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y40/00—Manufacture or treatment of nanostructures
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Composite Materials (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Manufacturing & Machinery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La présente invention est relative à des composés ω-silanyl-n alcanals, à leur procédé de préparation, à leur utilisation pour la fonctionnalisation de supports solides, au supports solides fonctionnalisés par ces composés, ainsi qu'à l'utilisation des supports solides ainsi fonctionnalisés pour l'immobilisation et/ou la synthèse de molécules biologiques d'intérêt.
FR0305391A 2003-04-30 2003-04-30 COMPOSES SILANYL-n ALCANAL, LEUR PROCEDE DE PREPARATION ET LEURS UTILISATIONS Expired - Fee Related FR2854400B1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR0305391A FR2854400B1 (fr) 2003-04-30 2003-04-30 COMPOSES SILANYL-n ALCANAL, LEUR PROCEDE DE PREPARATION ET LEURS UTILISATIONS
JP2006505821A JP4781261B2 (ja) 2003-04-30 2004-04-28 シラニル−ｎ−アルカナール化合物、その製造方法及びその使用
EP04742596A EP1626977A2 (fr) 2003-04-30 2004-04-28 Composes silanyl-n alcanal, leur procede de preparation et leurs utilisations
PCT/FR2004/001030 WO2004099219A2 (fr) 2003-04-30 2004-04-28 Composes silanyl-n alcanal, leur procede de preparation et leurs utilisations
US10/554,742 US7442823B2 (en) 2003-04-30 2004-04-28 Silanyl-n-alkanal compounds, method for production and use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0305391A FR2854400B1 (fr) 2003-04-30 2003-04-30 COMPOSES SILANYL-n ALCANAL, LEUR PROCEDE DE PREPARATION ET LEURS UTILISATIONS

Publications (2)

Publication Number Publication Date
FR2854400A1 true FR2854400A1 (fr) 2004-11-05
FR2854400B1 FR2854400B1 (fr) 2007-04-20

Family

ID=33155602

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0305391A Expired - Fee Related FR2854400B1 (fr) 2003-04-30 2003-04-30 COMPOSES SILANYL-n ALCANAL, LEUR PROCEDE DE PREPARATION ET LEURS UTILISATIONS

Country Status (5)

Country Link
US (1) US7442823B2 (fr)
EP (1) EP1626977A2 (fr)
JP (1) JP4781261B2 (fr)
FR (1) FR2854400B1 (fr)
WO (1) WO2004099219A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102428145B (zh) * 2009-03-18 2014-03-26 巴斯夫欧洲公司 改性的二氧化硅粒子和包含它们的防污聚合物组合物

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002051856A2 (fr) * 2000-12-22 2002-07-04 Commissariat A L'energie Atomique Procede d'immobilisation de sondes, en particulier pour realiser des puces biologiques

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002051856A2 (fr) * 2000-12-22 2002-07-04 Commissariat A L'energie Atomique Procede d'immobilisation de sondes, en particulier pour realiser des puces biologiques

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CHRISEY L A ET AL: "Covalent attachment of synthetic DNA to self-assembled monolayer films", NUCLEIC ACIDS RESEARCH, OXFORD UNIVERSITY PRESS, SURREY, GB, vol. 24, no. 15, 1996, pages 3031 - 3039, XP002149193, ISSN: 0305-1048 *
DATABASE REGISTRY XP002273087 *
MASKOS U ET AL: "OLIGNUCLEOTIDE HYBRIDISATIONS ON GLASS SUPPORTS: A NOVEL LINKER FOROLIGONUCLEOTIDE SYNTHESIS AND HYBRIDISATION PROPERTIES OF OLIGNUCLEOTIDES SYNTHESISED IN SITU", NUCLEIC ACIDS RESEARCH, OXFORD UNIVERSITY PRESS, SURREY, GB, vol. 20, no. 7, 1992, pages 1679 - 1684, XP000651031, ISSN: 0305-1048 *

Also Published As

Publication number Publication date
JP2006525979A (ja) 2006-11-16
WO2004099219A3 (fr) 2005-12-01
WO2004099219A2 (fr) 2004-11-18
EP1626977A2 (fr) 2006-02-22
US20070032672A1 (en) 2007-02-08
JP4781261B2 (ja) 2011-09-28
FR2854400B1 (fr) 2007-04-20
US7442823B2 (en) 2008-10-28

Similar Documents

Publication Publication Date Title
MA27668A1 (fr) 2,4-di(phenylamino) pyrimidines utilisees pour traiter des maladies neoplasiques, des troubles inflammatoires et des troubles du systeme immunitaire
MA31087B1 (fr) Derives d'amide et d'ester d'indazolyle pour traiter des troubles medies par le recepteur de glucocorticoïde.
FR2939135B1 (fr) Nouveaux composes 4-(azacycloalkyl)-benzene-1,3-diol comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
MA29772B1 (fr) Benzimidazoles substitues et procedes de preparation
TNSN03130A1 (fr) Inhibiteurs de protease du vih, compositions les contenant, leurs utilisations pharmaceutiques et matieres pour leur synthese
CY1112505T1 (el) Ανοσοκατασταλτικες ενωσεις και συνθεσεις
MA32466B1 (fr) Derives de triazole utiles pour le traitement de maladies
MA31936B1 (fr) Nouveaux composes et nouvelles compositions et leurs procedes d'utilisation
MA44851B1 (fr) Dérivés pyridinyltriazole substitués par des groupements amides et leurs utilisations
MA30232B1 (fr) Inhibiteurs de kinase bases sur l'hydantoine
MA29211B1 (fr) Composes de thienopyridinone et methodes therapeutiques
MA31276B1 (fr) Amides substitués, procédé de production et d'utilisation desdits amides.
MA30782B1 (fr) Amides substitues, procede de production et d'utilisation desdits amides
TNSN07393A1 (fr) Nouveaux ligands du recepteur h3 de l'histamine et leurs applications therapeutiques
MA30696B1 (fr) Derives de l'acide (3-amino-1,2,3,4-tetrahydro-9h-carbazol-9-yl)-acetique
MA31832B1 (fr) Dérivés de quinazolinedione, leur préparation et leurs applications thérapeutiques
MA30914B1 (fr) Dihydropyrazolones substituees utilisees dans le traitement de maladies cardiovasculaires et hematologiques.
MA30883B1 (fr) Nouveaux derives de 1,1 - dioxyde de 1.4 - benzothiepine substitues par des radicaux benzyle, leur procede de preparation, les produits pharmaceutiques comprenant ces composes et leur utilisation
MA32120B1 (fr) Nouveaux composes chimiques
MA27769A1 (fr) Dérivées de 2-acylamino-4-phenylthiazole, leur préparation et leur application en thérapeutique
MA30318B1 (fr) Composes de sulfonamide de pyrimidinyle inhibant l'adhesion leucocytaire mediee par vla-4
WO2004071442A3 (fr) Nouveaux composes bicycliques et compositions associees
MA26739A1 (fr) Sel mutuel d'amlodipine et d'atorvastatine, procede pour sa preparation et compositions pharmaceutiques les contenant
MA30089B1 (fr) (arylsulfonyl)-pyrasolopiperidines
MA30037B1 (fr) Compositions et procedes destines au traitement des troubles du snc

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 13

ST Notification of lapse

Effective date: 20161230